LON/0R29 (LON/0R29)

London Stock Exchange: LON/0R29 · USD

$447

-0.67 (-0.1%)· Recorded snapshot

Market cap	116.2B
Revenue (ttm)	8.7B
Net income (ttm)	2.2B
EPS (ttm)	$6.21
P/E (trailing)	54.0x
P/E (forward)	36.6x
Volume	2,944
Beta	1.46

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 8.7B
Net income (ttm): 2.2B
EPS (ttm): $6.21
P/E (trailing): 54.0x
P/E (forward): 36.6x
Market cap: 116.2B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E36.6

P25 n/aP50 n/aP75 n/a

Trailing P/E54

P25 n/aP50 n/aP75 n/a

ROE17.9

P25 n/aP50 n/aP75 n/a

ROIC24

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All LON/0R29 indicators

Market & fundamental data

Available fields

238

Groups with data

Currency

USD

Showing 238 of 238 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	GBP
Country	United States
Country code	UK
Earnings date	2026-10-20
Employees	17,021
Employees change	1,383
Employees growth	8.84%
Enterprise value	$113.2B
Exchange	London Stock Exchange
Financial currency	USD
Financial report date	2026-09-30
First seen	2026-05-10
Fiscal year end	December
Founded	1995
Industry	Medical Instruments & Supplies
Is primary listing	No
ISIN number	US46120E6023
Last earnings date	2026-10-20
Last refreshed	2026-10-28
Last stock split date	2021-10-05
Last stock split type	Forward
Market cap	$116.2B
Next earnings date	2027-01-19
Price	$446.54
Price currency	USD
Sector	Healthcare
SIC code	3845
Stock price date	2026-10-28
Symbol	lon/0R29
Website	https://www.intuitive.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	62.06x
Average P/E ratio (3Y)	66.16x
Average P/E ratio (5Y)	66.24x
Earnings yield	1.85%
EV/Earnings	50.83x
EV/EBIT	41.04x
EV/EBITDA	33.39x
EV/FCF	41.77x
EV/Sales	13.01x
FCF / EV yield	2.39%
FCF yield	2.33%
Forward P/E	36.58x
Graham number	94.83048
Graham upside	-78.76%
Industry P/E	69.82x
Lynch fair value	$101.48
Lynch upside	-77.27%
P/(FCF - SBC) ratio	55.82x
P/(OCF - SBC) ratio	47.39x
P/B ratio	9.57x
P/E ratio	53.97x
P/FCF ratio	42.86x
P/OCF ratio	37.71x
P/S ratio	13.32x
Price / tangible book value	10.12x
Price/EBITDA ratio	34.49x
Sector forward P/E	14.52x
Sector P/E	22.58x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	31.7%
EBITDA margin	38.61%
Effective tax rate	17.85%
FCF margin	31.17%
Gross margin	66.64%
Operating margin	31.7%
Pretax margin	31.26%
Profit margin	25.54%
Profit per employee	$130,865
Profitable quarters	35
Profitable years	14
Revenue per employee	$512,361
ROA	11.86%
ROA (5Y)	8.5%
ROCE	21.83%
ROE	17.93%
ROE (5Y)	14.94%
ROIC	23.97%
ROIC (5Y)	21.26%
SBC / revenue	7.21%
Tax / revenue	5.58%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	9.47%
EPS growth (Q)	-23.59%
EPS growth (QoQ)	-34.93%
EPS growth 10Y	14.92%
EPS growth 3Y	24.86%
EPS growth 5Y	12.27%
EPS growth years	3
FCF growth	58.41%
FCF growth (Q)	51.03%
FCF growth (QoQ)	17.14%
FCF growth 3Y	42.04%
FCF growth 5Y	13.81%
Gross profit growth	20.93%
Gross profit growth (Q)	23.71%
Gross profit growth 3Y	19.14%
Gross profit growth 5Y	15.26%
Net income growth	7.66%
Net income growth (Q)	-25.78%
Net income growth (QoQ)	-36.1%
Net income growth 3Y	24.93%
Net income growth 5Y	11.85%
Net income growth years	3
OCF growth	38.13%
OCF growth (Q)	45.55%
OCF growth (QoQ)	15.37%
OCF growth 10Y	14.67%
OCF growth 3Y	26.43%
OCF growth 5Y	13.73%
Operating income growth	30.34%
Operating income growth (Q)	33.58%
Operating income growth 3Y	28.81%
Operating income growth 5Y	15.49%
Revenue growth	20.45%
Revenue growth (Q)	21.7%
Revenue growth (QoQ)	5.41%
Revenue growth 10Y	16.02%
Revenue growth 3Y	19.11%
Revenue growth 5Y	16.1%
Revenue growth quarters	24
Revenue growth years	5

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-370.2M
Depreciation and amortization	$600.9M
EBIT	$2.8B
EBITDA	$3.4B
EPS	$6.21
Financing cash flow	$-3.5B
Free cash flow	$2.7B
Free cash flow minus SBC	$2.1B
Gross profit	$5.8B
Income taxes	$486.5M
Investing cash flow	$562.9M
Net cash flow	$130.2M
Net income	$2.2B
Operating cash flow minus SBC	$2.5B
Operating income	$2.8B
Revenue	$8.7B
Stock-based compensation	$629.2M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	32.46
Book value per share	$34.74
Debt / equity	0
Goodwill	$418.9M
Long-term assets	$8.2B
Long-term liabilities	$531.9M
Net cash (debt)	$3B
Net cash / market cap	2.62%
Net cash growth	-17.65%
Net debt / EBITDA	-0.9
Net debt / equity	-0.25
Net debt / FCF	-1.12
Piotroski F-Score	6
Property, plant and equipment	$4.3B
Shareholders' equity	$12.1B
Tangible book value	$11.5B
Tangible book value per share	$33.10
Total assets	$14.6B
Total cash	$3B
Total debt	$0
Total liabilities	$2.4B
WACC	12.3%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.6
Current assets	$6.3B
Current liabilities	$1.9B
Current ratio	3.33
Inventory turnover	1.98
Net working capital	$1.4B
Quick ratio	2.32
Working capital	$4.4B
Working capital turnover	1.38

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	1.75%
Shareholder yield	1.75%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	$412.90
1D price change	-0.15%
1M price change	10.61%
1M total return	10.61%
1W price change	1.67%
1W total return	1.67%
1Y price change	-18.67%
1Y return CAGR	-18.68%
1Y total return	-18.67%
20-day SMA	$426.23
200-day SMA	$434.93
3M price change	24.96%
3M total return	24.96%
3Y price change	72.47%
3Y return CAGR	19.92%
3Y total return	72.47%
50-day SMA	$399.44
50-day SMA vs 200-day SMA	50under200
52-week high	$603.32
52-week high date	2026-01-07
52-week low	$328.37
52-week low date	2026-07-23
5Y price change	27.49%
5Y return CAGR	4.98%
5Y total return	27.49%
6M price change	-5.5%
6M total return	-5.5%
All-time high	$616.00
All-time high date	2025-01-23
All-time low	$125.67
All-time low date	2020-03-17
Average true range (ATR)	$15.00
Average volume	2.9K
Beta (5Y)	1.46
Change from 52-week high	-25.99%
Change from 52-week low	35.99%
Change from all-time high	-27.51%
Change from all-time low	255.34%
Change from open	1.4%
Day's gap	-1.53%
Dollar volume	$1.3M
High price	$449.94
Low price	$435.00
Monthly RSI	50.01
Open price	$440.36
Position in 52-week range	77.24%
Previous close	$447.20
Price vs 150-day SMA	8.15%
Price vs 20-day SMA	4.77%
Price vs 200-day SMA	2.67%
Price vs 50-day SMA	11.79%
Relative volume	1.04
RSI	66.25
Sharpe ratio	-0.55
Sharpe ratio (3Y)	0.54
Sharpe ratio (5Y)	0.24
Sortino ratio	-0.57
Sortino ratio (3Y)	0.98
Sortino ratio (5Y)	0.51
Volume	2.9K
Weekly RSI	57.14
YTD price change	-21.84%
YTD total return	-21.84%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	344.6M
Shares change (QoQ)	-1.6%
Shares change (YoY)	-1.75%
Shares held by insiders	0.48%
Shares held by institutions	90.11%
Short ratio	3 days

Deeper analysis on LON/0R29

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this LON/0R29 report

Is a complete LON/0R29 research report available?

No complete published report is available for lon/0R29 (LON/0R29) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

LON/0R29 (LON/0R29)

Price

Financial snapshot

Fair-value bridge

Latest news · LON/0R29

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All LON/0R29 indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on LON/0R29

Frequently asked questions